Literature DB >> 7583924

Anti-human immunodeficiency virus type 1 antibodies of noninfected subjects are not related to autoantibodies occurring in systemic diseases.

R Kämmerer1, P Bürgisser, P C Frei.   

Abstract

Indeterminate Western blot (WB) (immunoblot) patterns for anti-human immunodeficiency virus type 1 (HIV-1) antibodies are often observed when testing serum samples from noninfected individuals. We investigated here the possible involvement of some frequently occurring autoantibodies (anti-SmB/B', U1snRNP [68 kDa, A, and C], Ro/SS-A [60 and 52 kDa], and Jo-1) in the generation of such indeterminate HIV-1 WB. In particular, the role of a reported sequence homology between p24 gag and the SmB/B' autoantigen was investigated. Serum samples were obtained from 50 healthy controls, 51 patients with systemic lupus erythematosus (SLE), 46 with systemic sclerosis, 6 with Sjögren's disease, 3 with mixed connective tissue disease, and 41 healthy subjects with persistent indeterminate HIV-1 WB. Reactivity to HIV-1 p24 gag was slightly but not significantly more frequent in patients with SLE than in controls (25.5% versus 14.0%; P > 0.1), whereas reactivity to HIV-1 p17 gag was significantly more frequent in the former subjects (23.5% versus 8.0%; P = 0.03). Simultaneous reactivity to p17 and p24 was observed in patients with SLE (11.8%; P = 0.014) or systemic sclerosis (8.7%; P = 0.049) but not in controls. There was no association found between the presence of any autoantibody and the occurrence of indeterminate HIV-1 WB nor between the presence of p24-reactive antibodies and anti-SmB/B'; this indicates that most p24-reactive antibodies are directed to epitopes other than the proline-rich sequences shared by p24 gag and SmB/B'.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583924      PMCID: PMC170179          DOI: 10.1128/cdli.2.4.458-461.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  23 in total

1.  Extensive antigenic mimicry by retrovirus capsid proteins.

Authors:  R F Garry
Journal:  AIDS Res Hum Retroviruses       Date:  1990-12       Impact factor: 2.205

2.  Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1.

Authors:  A Pinter; W J Honnen; S A Tilley; C Bona; H Zaghouani; M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Immunoblot reactivity of a non-HIV protein with human sera. Transfusion Safety Study Group.

Authors:  G L Norman; S S Barker; S Rasheed
Journal:  J Clin Lab Anal       Date:  1989       Impact factor: 2.352

4.  A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.

Authors:  N Talal; R F Garry; P H Schur; S Alexander; M J Dauphinée; I H Livas; A Ballester; M Takei; H Dang
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

5.  Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.

Authors:  J B Jackson; K L MacDonald; J Cadwell; C Sullivan; W E Kline; M Hanson; K J Sannerud; S L Stramer; N J Fildes; S Y Kwok
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

6.  Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.

Authors:  S L Josephson; N S Swack; M T Ramirez; W J Hausler
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

7.  Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy).

Authors:  N Talal; M J Dauphinée; H Dang; S S Alexander; D J Hart; R F Garry
Journal:  Arthritis Rheum       Date:  1990-06

8.  Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors.

Authors:  N L Dock; H V Lamberson; T A O'Brien; D E Tribe; S S Alexander; B J Poiesz
Journal:  Transfusion       Date:  1988 Sep-Oct       Impact factor: 3.157

9.  Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population.

Authors:  D E Tribe; D L Reed; P Lindell; W R Kenealy; B Q Ferguson; R Cybulski; D Winslow; D M Waselefsky; S R Petteway
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

10.  Cross-reactivity between autoimmune anti-U1 snRNP antibodies and neutralizing epitopes of HIV-1 gp120/41.

Authors:  A Douvas; Y Takehana
Journal:  AIDS Res Hum Retroviruses       Date:  1994-03       Impact factor: 2.205

View more
  2 in total

Review 1.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

2.  Multicenter evaluation of new double-antigen sandwich enzyme immunoassay for measurement of anti-human immunodeficiency virus type 1 and type 2 antibodies.

Authors:  P Burgisser; F Simon; M Wernli; T Wust; M F Beya; P C Frei
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.